Bayer obtains an exclusive worldwide license for MTA-cooperative PRMT5 inhibitor from Suzhou Puhe BioPharma for selective ...

The following is a summary of “Ocular features of VEXAS syndrome: a systematic review and meta-analysis,” published in the ...

Bayer, Puhe BioPharma ink global license agreement for clinical phase I PRMT5 inhibitor: Berlin, Germany Friday, March 28, 2025, 13:00 Hrs [IST] Bayer and Suzhou Puhe BioPharma Co ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Food Republic spoke with Jem Mantiri, a vegan food recipe blogger at The Fruity Jem, about lentils and whether they're ...

Bayer and Suzhou Puhe BioPharma Co. Ltd., a clinical-stage biotechnology company, on Wednesday announced that they have entered into a global license agreement for Puhe BioPharma's oral, small ...

When Laura Taft, 62, first started supplementing with creatine at the suggestion of her trainer, it was with her muscles in ...

Your Horse has teamed up with Horslyx to offer one lucky winner the chance to sort all of their horse’s nutritional needs for ...

BioCraft Pet Nutrition has received registration from Austrian authorities to sell its cultivated mouse meat ingredient to EU ...

The ointment, named as Aqua Dramahas, was developed after two years of research by Dr Siddhnath, an assistant professor at ...

Affiliate content. Discover the best-rated joint supplement of 2025, designed to support mobility, reduce pain, and promote ...